Programme : Cell Symposia: Microbiome and Host Health

Final Program

Sunday, May 12, 2013
11: 00	Registration, White Plains Foyer
14:00 – 14:10	Opening Remarks, White Plains 3,4,5
Session 1: Composition and Diversity of the Microbiome
14:10 - 14:45	Rob Knight, University of Colorado, USA Effect size and cross-species translatability of microbiome studies [Inv.1]
14:45 - 15:20	Peer Bork, EMBL Heidelberg, Germany Metagenomic analysis of the human gut microbiome: Variation, stratification and associations with disease [Inv.2]
15:20 - 15:35	Short Talk: N. Segata, Harvard School of Public Health, USA, University of Trento, Italy Automating and improving taxonomic assignment with a high-resolution microbial phylogeny for microbiome studies [O1]
15:35 - 15:50	Short Talk: J.M. Fettweis, Vaginal Microbiome Consortium at VCU, Virginia Commonwealth University, USA Species diversity of the human vaginal microbiome [O2]
15:50 - 16:20	Coffee Break, New Orleans 1,2,3 & Nashville Room
16:20 - 16:55	Elhanan Borenstein, University of Washington, USA Towards a predictive systems-level model of the human microbiome [Inv.3]
16:55 - 17:10	Short Talk: K. Hase, The University of Tokyo, Japan, RCAI, Japan Commensal microbiota shapes the gut immune system through epigenetic [O3]
17:10 - 17:25	Short Talk: J. Oh, National Institutes of Health, USA Primary immunodeficiencies alter the landscape of the human skin microbiome [O4]
17:30	Welcome Reception, New Orleans 1,2,3 & Nashville Room
Monday, May 13, 2013
08:00 - 08:30	Registration, White Plains Foyer
08:30 - 09:20	Keynote Presentation: Skip W. Virgin, Washington University School of Medicine, USA Interactions between the mammalian virome, disease susceptibility genes, and the phenome [Inv.4]
Session 2: Microbiome in Health
09:20 - 09:55	Fredrik Bäckhed, University of Gothenburg, Sweden Gut microbial regulation of glucose metabolism [Inv.5]
09:55 - 10:25	Coffee Break, New Orleans 1,2,3 & Nashville Room
10:25 - 11:00	Dennis L. Kasper, Harvard Medical School, USA Plasmacytoid dendritic cells mediate immunoregulation by the microbiota [Inv.6]
11:00 - 11:35	Sven Pettersson, Karolinska Institutet,Sweden The gut microbiome and its role in mammalian development in early life [Inv.7]
11:35 - 12:10	Yasmine Belkaid, National Institute of Allergy and Infectious Disease, NIH, USA Compartmentalized control of tissue immunity by commensals [Inv.8]
12:10 - 15:30	Poster Session I & Lunch, New Orleans 1,2,3 & Nashville Room
Session 3: Perturbations to the Microbiome
15:30 - 16:05	Ruth E. Ley, Cornell University, USA Host control of the microbiome [Inv.9]
16:05 - 16:40	Philippe Sansonetti, Institute Pasteur, France From symbiosis to homeostasis, from danger signaling to pathogenesis: Novel facets of gut cellular microbiology [Inv.10]
16:40 - 17:10	Coffee Break, New Orleans 1,2,3 & Nashville Room
17:10 - 17:45	Sarkis K. Mazmanian, California Institute of Technology, USA Specific and stable colonization by Bacteroides of the gut microbiota [Inv.11]
17:45 - 18:00	Short Talk: F. Cabreiro, University College London, UK Metformin retards aging in the nematode C. elegans by altering microbial folate and methionine metabolism [O5]
18:00 - 18:15	Short Talk: Y. Soen, Weizmann Institute of Science, Israel Bacterial mediated prevention of transgenerational inheritance of response to stress in flies [O6]
19:30 - 21:30	Meet the Speakers Dinner, Rios Restaurant & Bar
Tuesday , May 14, 2013
Session 4: Microbiome in Disease, White Plains 3,4,5
09:00 – 09:35	Wendy S. Garrett, Harvard School of Public Health, Harvard Medical School, and Dana-Farber Cancer Institute, USA Gut microbiota in colitis and colorectal cancer [Inv.12]
09:35 - 09:50	Short Talk: E. Elinav, Weizmann Institute of Science, Israel , Yale University, USA Transmissible cancer mediated by microbiome-induced activation of epithelial IL-6 signaling [O7]
09:50 - 10:05	Short Talk: A.D. Kostic, Harvard Medical School, USA, Broad Institute of M.I.T. and Harvard, USA Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor immune microenvironment [O8]
10:05 - 10:35	Coffee Break, New Orleans 1,2,3
10:35- 11:10	Eric Pamer, Memorial Sloan-Kettering Cancer Center, USA Intestinal microbiota and immune defense against infection [Inv.13]
11:10 - 11:25	Short Talk: A.S. Bhatt, Broad Institute, USA, Dana-Farber Cancer Institute, USA “The gut, perturbed” – Sequence-based discovery of a novel, disease-associated bacterium in a post-stem cell transplantation colitis syndrome [O9]
11:25 - 12:00	Kenya Honda, RIKEN IMS, Japan Clostridia strains from human microbiota for Treg induction [Inv.14]
12:00 - 15:30	Poster Session II & Lunch, New Orleans 1,2,3 & Nashville Room
Session 5: Exploring Therapeutic Opportunities
15:30 - 16:05	Michael Fischbach, University of California San Francisco, USA A gene-to-molecule approach to the discovery and characterization of natural products [Inv.15]
16:05 - 16:40	Peter J. Turnbaugha, Harvard University, USA Drug metabolism and resistance in the human gut microbiome [Inv.16]
16:40 - 16:55	Short Talk: D. An, Harvard Medical School, USA A bacterial symbiosis molecule defines host intestinal natural killer T cell homeostasis [O10]
16:55 - 17:30	Fergus Shanahan, University College Cork, Ireland Mining the microbiome for new therapeutics [Inv.17]
17:30 - 17:35	Closing Remarks
17:35 – 18:00	Networking Coffee Break